Topics

Human medicines European public assessment report (EPAR): Roteas, edoxaban, Stroke,Venous Thromboembolism, Date of authorisation: 19/04/2017, Revision: 4, Status: Authorised

12:10 EST 15 Jan 2020 | European Medicines Agency

Human medicines European public assessment report (EPAR): Roteas, edoxaban, Stroke,Venous Thromboembolism, Date of authorisation: 19/04/2017, Revision: 4, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Roteas, edoxaban, Stroke,Venous Thromboembolism, Date of authorisation: 19/04/2017, Revision: 4, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Roteas, edoxaban, Stroke,Venous Thromboembolism, Date of authorisation: 19/04/2017, Revision: 4, Status: Authorised"

Quick Search

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...